Your browser doesn't support javascript.
loading
Controversies in the Management of Clinical Stage I Seminoma: Carboplatin a Decade in-Time to Start Backing Out.
van de Wetering, Rune A W; Sleijfer, Stefan; Feldman, Darren R; Funt, Samuel A; Bosl, George J; de Wit, Ronald.
Affiliation
  • van de Wetering RAW; Rune A.W. van de Wetering and Stefan Sleijfer, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Darren R. Feldman, Samuel A. Funt, and George J. Bosl, Memorial Sloan Kettering Cancer Center, New York, NY; and Ronald de Wit, Erasmus Medical Center Cancer Institute, Rotterdam, the
  • Sleijfer S; Rune A.W. van de Wetering and Stefan Sleijfer, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Darren R. Feldman, Samuel A. Funt, and George J. Bosl, Memorial Sloan Kettering Cancer Center, New York, NY; and Ronald de Wit, Erasmus Medical Center Cancer Institute, Rotterdam, the
  • Feldman DR; Rune A.W. van de Wetering and Stefan Sleijfer, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Darren R. Feldman, Samuel A. Funt, and George J. Bosl, Memorial Sloan Kettering Cancer Center, New York, NY; and Ronald de Wit, Erasmus Medical Center Cancer Institute, Rotterdam, the
  • Funt SA; Rune A.W. van de Wetering and Stefan Sleijfer, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Darren R. Feldman, Samuel A. Funt, and George J. Bosl, Memorial Sloan Kettering Cancer Center, New York, NY; and Ronald de Wit, Erasmus Medical Center Cancer Institute, Rotterdam, the
  • Bosl GJ; Rune A.W. van de Wetering and Stefan Sleijfer, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Darren R. Feldman, Samuel A. Funt, and George J. Bosl, Memorial Sloan Kettering Cancer Center, New York, NY; and Ronald de Wit, Erasmus Medical Center Cancer Institute, Rotterdam, the
  • de Wit R; Rune A.W. van de Wetering and Stefan Sleijfer, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Darren R. Feldman, Samuel A. Funt, and George J. Bosl, Memorial Sloan Kettering Cancer Center, New York, NY; and Ronald de Wit, Erasmus Medical Center Cancer Institute, Rotterdam, the
J Clin Oncol ; 36(9): 837-840, 2018 03 20.
Article in En | MEDLINE | ID: mdl-29389229
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testicular Neoplasms / Carboplatin / Seminoma Limits: Humans / Male Language: En Journal: J Clin Oncol Year: 2018 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testicular Neoplasms / Carboplatin / Seminoma Limits: Humans / Male Language: En Journal: J Clin Oncol Year: 2018 Document type: Article Country of publication: United States